Abstract |
Patients with attacks of re-entrant supraventricular tachycardia (SVT) frequently present to the emergency department (ED). The Valsalva manoeuvre (VM) is the most effective and safe vagal manoeuvre and advocated as the first-line treatment in stable patients but has a relatively low cardioversion success rate. Improving its efficacy would reduce patients' exposure to the side effects and complications of second-line treatments and has other potential benefits. We describe a modification to the VM, which is currently being studied, and present the case of a 23-year-old patient who was successfully treated with this modified VM after a previous near-fatal complication of direct current (DC) cardioversion.
|
Authors | Andrew Appelboam, James Gagg, Adam Reuben |
Journal | BMJ case reports
(BMJ Case Rep)
Vol. 2014
(Jul 08 2014)
ISSN: 1757-790X [Electronic] England |
PMID | 25006052
(Publication Type: Case Reports, Journal Article)
|
Copyright | 2014 BMJ Publishing Group Ltd. |
Topics |
- Electric Countershock
(adverse effects)
- Electrocardiography
- Humans
- Male
- Recurrence
- Tachycardia, Supraventricular
(therapy)
- Valsalva Maneuver
- Ventricular Fibrillation
(etiology, prevention & control)
- Young Adult
|